Valve Surgery Patient Mobility and Recovery Metrics Under ERAS Protocols

A single-center retrospective cohort study of 48 valvular heart disease patients undergoing valve surgery. The dataset, authored by Chengyao Xu and last updated in March 2026, compares outcomes for patients on quadruple therapy with SGLT2 inhibitors versus triple therapy without, assessing mobility, stress ulcer risk, and fall risk at multiple perioperative timepoints.

Use Cases

• Modeling the relationship between ICU duration and functional recovery based on reported multivariate analysis correlates.
• Comparing early mobility impairment between patient groups based on Activities of Daily Living (ADL) scores.
• Analyzing the mitigation of SGLT2i-associated risks by ERAS protocols based on stress ulcer risk (Braden scale) and fall risk (Modified Thomas scale) metrics.
• Investigating associations between laboratory parameters (platelets, albumin, NT-proBNP) and mobility outcomes as identified in the study.

Strengths

• Includes data for 48 patients with 34 in the SGLT2i group and 14 in the control group, allowing for comparative analysis.
• Reports primary outcomes measured at multiple perioperative timepoints, providing a temporal view of recovery.
• Multivariate analysis identified specific mobility correlates (ICU duration, mechanical ventilation time, platelets, albumin, NT-proBNP) with correlation coefficients ranging |r|=0.368–0.625.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Data is from a single-center study, which may limit generalizability.

Provenance

Source

Chengyao Xu via figshare.

Collection Method

Single-center, retrospective cohort study.

Time Range

Conducted from (Start Date) to (End Date) as per description.

Freshness

Last updated 2026-03-17 13:06:37; freshness should be verified.

Geography

Single-center location, geography not specified.